Table 4.
Multivariable analysis: Predictors of NOCAs, AF, VT/VF.
| NOCAs | AF | VT/VF | ||||||
|---|---|---|---|---|---|---|---|---|
| Variables | OR (CI, 95%) | p -value | Variables | OR (CI, 95%) | p -value | Variables | OR (CI, 95%) | p -value |
| Age | 1.01 (0.99–1.04) | 0.369 | Age | 1.02 (0.98–1.05) | 0.267 | Age | 0.99 (0.96–1.04) | 0.972 |
| Gender, male | 0.82 (0.43–1.56) | 0.537 | RWMA | 0.82 (0.24–1.90) | 0.455 | RWMA | 0.76 (0.18–3.13) | 0.702 |
| STEMI | 1.27 (0.64–2.52) | 0.493 | STEMI | 1.83 (0.84–3.98) | 0.124 | STEMI | 0.71 (0.23–2.27) | 0.570 |
| ECG-to-balloon time | 0.97 (0.94–0.99) | 0.042 | ECG-to-balloon time | 0.97 (0.93–1.00) | 0.062 | ECG-to-balloon time | 0.96 (0.90–1.02) | 0.194 |
| Killip≥2 | 2.43 (1.32–4.49) | 0.004 | Killip≥2 | 2.34 (1.15–4.77) | 0.019 | Killip≥2 | 2.54 (0.95–6.85) | 0.064 |
| VT or CA at presentation | 7.29 (2.46–21.63) | <0.001 | VT or CA at presentation | 2.77 (0.67–11.42) | 0.160 | VT or CA at presentation | 17.3 (4.99–60.0) | <0.001 |
| Admission BGL | 0.99 (0.98–1.01) | 0.543 | Peak Hs-TnI, ng/L | 1.00 (1.00–1.01) | 0.776 | Peak Hs-TnI, ng/L | 1.00 (1.00–1.01) | 0.267 |
| LVEF | 0.95 (0.92–0.98) | <0.001 | LVEF | 0.94 (0.90–0.97) | <0.001 | LVEF | 0.95 (0.91–0.99) | 0.043 |
| Complete revascularization | 0.72 (0.39–1.34) | 0.302 | Complete revascularization | 0.75 (0.38–1.48) | 0.401 | Complete revascularization | 0.62 (0.24–1.57) | 0.310 |
| I.V. insulin | 1.25 (0.50–3.08) | 0.635 | I.V. insulin | 1.12 (0.56–2.21) | 0.756 | I.V. insulin | 0.75 (0.29–1.91) | 0.547 |
| SGLT2-i | 0.35 (0.14–0.86) | 0.022 | SGLT2-i | 0.40 (0.14–1.14) | 0.086 | SGLT2-i | 0.20 (0.04–0.97) | 0.046 |
BGL, blood glucose level; CA, cardiac arrest; ECG, electrocardiogram; Hs-TnI, high sensitivity Troponin I; LVEF, Left ventricular ejection fraction; SGLT2-i, Sodium-glucose cotransporter 2 inhibitors; RWMA, regional wall motion abnormalities; STEMI, ST-elevation myocardial infarction; VT, ventricular tachycardia.